{"id":8843,"date":"2024-05-02T20:00:33","date_gmt":"2024-05-02T18:00:33","guid":{"rendered":"https:\/\/www.seventure.fr\/?p=8843"},"modified":"2024-05-03T08:23:07","modified_gmt":"2024-05-03T06:23:07","slug":"karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis","status":"publish","type":"post","link":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/","title":{"rendered":"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-8843","post","type-post","status-publish","format-standard","hentry","category-seventure-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Annick Aubert\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/\"},\"author\":{\"name\":\"Annick Aubert\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#\\\/schema\\\/person\\\/44ea53a59fb31bf4b0785993c3b80072\"},\"headline\":\"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis\",\"datePublished\":\"2024-05-02T18:00:33+00:00\",\"dateModified\":\"2024-05-03T06:23:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/\"},\"wordCount\":26,\"articleSection\":[\"Seventure\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/\",\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/\",\"name\":\"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis | Seventure\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#website\"},\"datePublished\":\"2024-05-02T18:00:33+00:00\",\"dateModified\":\"2024-05-03T06:23:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#\\\/schema\\\/person\\\/44ea53a59fb31bf4b0785993c3b80072\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/#\\\/schema\\\/person\\\/44ea53a59fb31bf4b0785993c3b80072\",\"name\":\"Annick Aubert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g\",\"caption\":\"Annick Aubert\"},\"url\":\"https:\\\/\\\/www.seventure.fr\\\/en\\\/author\\\/annick-aubert\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/","twitter_misc":{"Written by":"Annick Aubert"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/#article","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/"},"author":{"name":"Annick Aubert","@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072"},"headline":"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis","datePublished":"2024-05-02T18:00:33+00:00","dateModified":"2024-05-03T06:23:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/"},"wordCount":26,"articleSection":["Seventure"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/","url":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/","name":"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2024-05-02T18:00:33+00:00","dateModified":"2024-05-03T06:23:07+00:00","author":{"@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072"},"breadcrumb":{"@id":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/en\/karius-raises-100m-co-led-by-khosla-ventures-5am-ventures-and-gilde-healthcare-to-expand-access-to-advanced-genomic-diagnostics-in-infectious-disease-addressing-antimicrobial-resistance-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072","name":"Annick Aubert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g","caption":"Annick Aubert"},"url":"https:\/\/www.seventure.fr\/en\/author\/annick-aubert\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/8843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=8843"}],"version-history":[{"count":0,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/8843\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media?parent=8843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/categories?post=8843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/tags?post=8843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}